IL6 and hydrops fetalis: Markers of inflammation [interleukin 6, high-sensitivity C-reactive protein (IL-6, hsCRP)] and myocardial damage (troponin) were not of added value.68 The identification of plasma biomarkers in HF is an area of intense research interest and may impact on clinical management in the future.64